Atovaquone/Proguanil Hydrochloride Glenmark Pharmaceuticals Eurpoe

Atovaquone/Proguanil Hydrochloride by Glenmark Pharmaceuticals Europe is a combination medication used for malaria prevention and treatment. This oral medication is designed to help manage and prevent malaria in adults and children.

Atovaquone/Proguanil Hydrochloride is primarily used for the prevention and treatment of malaria. This medication is often prescribed for travelers to areas where malaria is common, providing protection against the disease. It works by interfering with the growth of parasites that cause malaria, helping to reduce the risk of infection or manage existing cases.

Common effects of Atovaquone/Proguanil Hydrochloride may include headache, stomach pain, nausea, and vomiting. Some users might experience diarrhea or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone/Proguanil Hydrochloride should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment to ensure effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Atovaquone/Proguanil Hydrochloride may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided as it can increase the risk of side effects. Always consult a healthcare professional before starting any new medication.